Amphastar Urges 1st Circ. To Nix Rivals' Antitrust Immunity
Amphastar Pharmaceuticals Inc. urged the First Circuit on Monday to revive its suit accusing Momenta Pharmaceuticals Inc. and Sandoz Inc. of trying to block a competing generic version of a blood...To view the full article, register now.
Already a subscriber? Click here to view full article